Vol. 8 No. 3 (2026), Series A
Vol. 8 No. 3 (2026)

3,4,5-TRIMETOKSIBENZOY KISLOTANING PROPIL EFIRI SINTEZI VA BIOLOGIK FAOLLIGI

Series A
Published 2026-06-27
Yo’ldoshev Hamidulla Abdujabbor o’g’li
O’zbekiston Milliy Universiteti 3-kurs talabasi
Abdumannopova Nasibaxon Baxodir qizi
O’zbekiston Milliy Universiteti 3-kurs talabasi
Kadirova Shoxida Ozotboevna
O’zMU kimyo fakulteti tayanch doktaranti
Yuldasheva Muhabbat Razzoqberdievna
O’zMU kimyo fakulteti professori
Qoʻchqorboyeva Nilufar Alijon qizi
PDF

Keywords

3,4,5-trimetoksi benzoy kislota, biologik faollik, PASS online, IQ, Mass, katalizatorlar( H2SO4, FeCl3, nano PVC ZnCl2)

How to Cite

3,4,5-TRIMETOKSIBENZOY KISLOTANING PROPIL EFIRI SINTEZI VA BIOLOGIK FAOLLIGI. (2026). Qo‘qon DPI. Ilmiy Xabarlar Jurnali, 8(3), 555-561. https://doi.org/10.70728/
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Ushbu ish 3,4,5-trimetoksibenzoy kislota bilan propil spirtining turli katalizatorlar ishtirokida borishiga qaratilgan. Efirning xromotomass spektroskopiyasi va IQ spektrlari tahlil qilingan, biologic faolligi Pass online platformasi orqali tekshirilgan

PDF

References

1. Silva RHN et al. Molecular Modeling and In Vitro Evaluation of Piplartine Analogs against Oral Squamous Cell Carcinoma. Molecules. 2023;28:1675. doi:10.3390/molecules28041675.

2. Boaventura MAD et al. Acetylcholinefirase inhibition and antimicrobial activity of hydroxyl amides synthesized from natural products derivatives. An Acad Bras Cienc. 2018;90:1945–1954. doi:10.1590/0001-3765201820170451.

3. Kaur R et al. Synthesis of substituted gallic acid peptide derivatives and evaluation of biological activities. Int J Pharm Sci Rev Res. 2014;28:16–21.

4. Braconi L et al. New Dual P-Glycoprotein and hCA XII Inhibitors as MDR Reversers in Cancer Cells. J Med Chem. 2022;65:14655–14672. doi:10.1021/acs.jmedchem.2c01175.

5. Dilweg MA et al. Exploring novel dilazep derivatives as hENT1 inhibitors. Purinergic Signal. 2025;21:289–316. doi:10.1007/s11302-024-10026-x.

6. Gomes LR et al. Crystal structures of three 3,4,5-trimethoxybenzamide-based derivatives. Acta Crystallogr E. 2016;72:675–682. doi:10.1107/S2056989016005958.

7. Neves AR et al. Derivatives of Trimethoxybenzoic Acid and Gallic Acid as Potential Efflux Pump Inhibitors. Int J Mol Sci. 2022;23:14468. doi:10.3390/ijms232214468.

8. Lagunin A.A., Stepanchikova A.V., Filimonov D.A., Poroikov V.V. PASS: prediction of activity spectra for biologically active substances. Bioinformatics, 2000. DOI: 10.1093/bioinformatics/16.8.747

9. Rintala‑Dempsey A., Kothe U. Eukaryotic pseudouridine synthases and RNA modification enzymes. RNA Biology, 2017. DOI: 10.1080/15476286.2017.1294293

10. Penzo M. RNA pseudouridylation in physiology and medicine. Genes, 2017. DOI: 10.3390/genes8110301

11. Xiong Y., Steitz T.A. Mechanism of transfer RNA maturation by CCA‑adding enzyme. Nature. DOI: 10.1038/nature02711

12. Hori H. Transfer RNA modification enzymes and their biological roles. Frontiers in Cell and Developmental Biology. DOI: 10.3389/fcell.2024

13. Kraut J.A., Madias N.E. Metabolic acidosis: pathophysiology and diagnosis. Nature Reviews Nephrology, 2010. DOI: 10.1038/nrneph.2010.33

14. Laine L. Upper gastrointestinal bleeding. Gastroenterology, 2016. DOI: 10.1053/j.gastro.2016.02.009

15. Ference B.A. Hypercholesterolemia and cardiovascular disease. Nature Reviews Cardiology, 2017. DOI: 10.1038/nrcardio.2017.139

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.